Global health & development

Debate around health systems often focuses on lives saved by new or improved medicines and fails to consider the long-term development of scientific research capacity in low and middle income countries, and how this affects the health of a country’s population and its economic growth. A recognition that health, education and industrial policy are interlinked is at the core of Innogen’s approach.

Projects

Supporting Africa’s innovation strategy

12 December 2019

In November, Geoff Banda, Innogen Deputy Director, attended the launch of The Health Research and Innovation Strategy for Africa 2018-2030, developed by the African Union Development Agency (AUDA)-NEPAD, and spoke at the 2nd Vaccine Manufacturing Forum.

Analysis of the social impact of lockdowns in Africa

19 July 2020

As part of TIBA (the NIHR Global Health Research Unit Tackling Infections to Benefit Africa at the University of Edinburgh), Geoff Banda and Vera Florida Mugittu have contributed to a new report on the social impact of Covid-19 mitigation measures on nine African countries.

Creative states: Is state-led risk-taking the answer to post-Covid-19 recovery?

28 April 2021

Writing in the RSA Journal, Innogen Director, Theo Papaioannou, examines how the entrepreneurial state could work in practice.

Making a global health research partnership work

15 June 2023

Writing in the BMJ Global Health, Francisca Mutapi, Geoff Banda and Mark Woolhouse share their actionable recommendations for successful equitable global health research partnerships.